Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study
International Journal of Epidemiology · 2026
DOI: 10.1093/ije/dyag210 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Epidemiology, 2026. Verfasst von Layan Sukik und 22 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar. Hauptthemen laut MEDLINE: Vaccine Efficacy, COVID-19, COVID-19 Vaccines, Epidemiologic Research Design. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Research Development and Innovation Council.
Abstract (Originalsprache)
Background
Observational studies are central to assessing vaccine effectiveness and informing public health policy. The two most common designs are test-negative case-control and cohort studies, yet direct comparisons of their performance using the same population, data sources, and analytic strategies remain rare. This study compares these two designs within a national population using harmonized analytic approaches.
Methods
Nationwide, matched test-negative case-control and retrospective cohort studies were conducted in Qatar between 1 January 2021 and 18 December 2021 to assess the effectiveness of the coronavirus disease (COVID-19) primary series of BNT162b2 and mRNA-1273 against any severe acute respiratory syndrome coronavirus 2 infection, symptomatic infection, and severe COVID-19.
Results
In the test-negative design, BNT162b2 effectiveness was 71.0% [95% confidence interval (CI): 70.1–71.9] against any infection, 75.6% (95% CI: 74.2–77.0) against symptomatic infection, and 96.3% (95% CI: 95.2–97.2) against severe COVID-19. In the cohort design, after adjustment for testing rate, corresponding effectiveness was 78.0% (95% CI: 77.1–78.9), 81.2% (95% CI: 79.8–82.5), and 98.0% (95% CI: 96.6–98.8), respectively. Both designs demonstrated similar, rapid, and largely linear waning of effectiveness in both magnitude and pattern. Test-negative design estimates lay between cohort estimates with and without adjustment for testing rate. Similar results were observed for mRNA-1273.
Conclusions
Both designs yielded consistent effectiveness estimates across vaccines and clinically relevant outcomes, with only modest differences related to handling of health-seeking behavior. These findings demonstrate that, when rigorously implemented using quality data and harmonized analytic strategies, both designs produce comparable effectiveness estimates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
- Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.
- Hamad Medical Corporation, Doha, Qatar.
- Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
- Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom.
- Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
ORCID-Profile: Layan Sukik, Pradipta Paul, Houssein H Ayoub, Patrick Tang, Andrew Jeremijenko, Gheyath K Nasrallah, Hiam Chemaitelly, Laith J Abu-Raddad
Förderung
- Qatar Research Development and Innovation Council
Zitieren
APA
Sukik, L., Paul, P., Ayoub, H. H., Coyle, P., Tang, P., Hasan, M. R., Yassine, H. M., Thani, A. A. A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G. K., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., …, & Abu-Raddad, L. J. (2026). Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study. International Journal of Epidemiology. https://doi.org/10.1093/ije/dyag210
Vancouver
Sukik L, Paul P, Ayoub HH, Coyle P, Tang P, Hasan MR, et al. Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study. International Journal of Epidemiology. 2026. doi:10.1093/ije/dyag210
BibTeX
@article{Sukik2026,
author = {Sukik, Layan and Paul, Pradipta and Ayoub, Houssein H and Coyle, Peter and Tang, Patrick and Hasan, Mohammad R and Yassine, Hadi M and Thani, Asmaa A Al and Al-Kanaani, Zaina and Al-Kuwari, Einas and Jeremijenko, Andrew and Kaleeckal, Anvar Hassan and Latif, Ali Nizar and Shaik, Riyazuddin Mohammad and Abdul-Rahim, Hanan F and Nasrallah, Gheyath K and Al-Kuwari, Mohamed Ghaith and Butt, Adeel A and Al-Romaihi, Hamad Eid and Al-Thani, Mohamed H and Al-Khal, Abdullatif and Chemaitelly, Hiam and Abu-Raddad, Laith J},
title = {Evaluating COVID-19 vaccine effectiveness across epidemiologic designs: test-negative case-control versus retrospective cohort analyses in a nationwide study},
journal = {International Journal of Epidemiology},
year = {2026},
doi = {10.1093/ije/dyag210}
}
EUVIMED